| Patents for C12N 5 - Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor (182,629) |
|---|
| 07/05/2005 | US6914044 Compounds and methods for modulating cell adhesion |
| 07/05/2005 | US6913932 Formaldehyde-ammonium salt complexes for the stabilization of blood cells |
| 07/05/2005 | US6913927 Non-adenoviral gene product-based complementing cells for adenoviral vectors |
| 07/05/2005 | US6913926 Use of a pituitary tumor transforming gene peptide which has the ability to regulate endogenous PTTG1 expression and/or function in a dominant negative manner |
| 07/05/2005 | US6913925 Producing conditionally-immortalized brain tissues for treatment of parkinson's and nervous system disorders |
| 07/05/2005 | US6913924 Population of interferon producing cells |
| 07/05/2005 | US6913922 Serotype of adenovirus and uses thereof |
| 07/05/2005 | US6913918 Isolated polypeptide |
| 07/05/2005 | US6913916 Elongase genes and uses thereof |
| 07/05/2005 | US6913907 Enterococcus faecalis polynucleotides encoding EF059 |
| 07/05/2005 | US6913894 Monoclonal antibody for use in the treatment of tumors |
| 07/05/2005 | US6913892 Method of obtaining compositions comprising Y4 specific compounds |
| 07/05/2005 | US6913755 Amino acid substituted DNA sequences for use as vaccines against streptococcus |
| 07/05/2005 | US6913752 Characterized by the loss of its capability to reproductively replicate in human cell lines. |
| 07/05/2005 | US6913749 Immunogenic polypeptide comprising a self Immunoglobin E (IgE) portion and a non-self IgE portion, to induce an anti-self IgE response in a mammal; treating diseases such as allergies |
| 07/05/2005 | CA2283789C Dna polymerases having improved labeled nucleotide incorporation properties |
| 07/05/2005 | CA2215793C Use of neuronal apoptosis inhibitor protein (naip) |
| 07/05/2005 | CA2129663C Biosynthetic binding protein for cancer marker |
| 07/05/2005 | CA2127463C Biodegradable polymers for cell transplantation |
| 06/30/2005 | WO2005059149A2 Improved protein production |
| 06/30/2005 | WO2005059140A1 Transgenic plants with reduced level of saturated fatty acid and methods for making them |
| 06/30/2005 | WO2005059121A2 Dominant gene suppression transgenes and methods of using same |
| 06/30/2005 | WO2005059120A1 Methods of preventing transplantation rejection by creating immunologically neutral stem cells using gene silencing technology |
| 06/30/2005 | WO2005059119A2 Differentiated cells |
| 06/30/2005 | WO2005059118A2 Stem cell targeting using magnetic particles |
| 06/30/2005 | WO2005059117A1 Cell picking tool including molding with cell-adhesive recessed structure and method of cell manipulation |
| 06/30/2005 | WO2005059116A1 Methods for clonal derivation of human blastocyst-derived stem cell lines |
| 06/30/2005 | WO2005059115A1 Compositions and methods for enhancing neuroprotection via administration of stem cells and blood brain barrier permeabilizers |
| 06/30/2005 | WO2005059114A1 Fat composition for promoting animal cell growth, medium for culturing animal cells containing the composition and external skin preparation |
| 06/30/2005 | WO2005059113A1 Stem cells |
| 06/30/2005 | WO2005059092A1 Substrate for cell culture, producing method thereof and screening method for cell culture conditions utilizing the same |
| 06/30/2005 | WO2005059089A1 Culture medium for cultivating human progenitor cells and its use for the proliferation of said cells for autologous posttransplantation purposes |
| 06/30/2005 | WO2005059088A1 Cultured cell and method and apparatus for cell culture |
| 06/30/2005 | WO2005058207A1 Particulate cartilage system |
| 06/30/2005 | WO2005058032A1 Tissue preservation media |
| 06/30/2005 | WO2005040332A3 Method and bioreactor for the cultivation and stimulation of three-dimensional vital and mechanically-resistant cell transplants |
| 06/30/2005 | WO2005026334A8 Human tumour growth patterns |
| 06/30/2005 | WO2005025494A3 Vaccine immunotherapy for immune suppressed patients |
| 06/30/2005 | WO2005023988A3 Modulation of cell intrinsic strain to control matrix synthesis, secretion, organization and remodeling |
| 06/30/2005 | WO2005021576A3 Methods for for modeling gpcrs and for producing ligand blocking and receptor activating antibodies for same |
| 06/30/2005 | WO2005009369A3 A ca6 antigen-specific cytotoxic conjugate and methods of using the same |
| 06/30/2005 | WO2004108766A3 Anti-hgf-r antibodies and their use |
| 06/30/2005 | WO2004103293A3 Modulators of the p2y10 receptor useful in altering t lymphocyte function |
| 06/30/2005 | WO2004099385A3 Telomere elongation |
| 06/30/2005 | WO2004093788A3 Desmoglein 4 is a novel gene involved in hair growth |
| 06/30/2005 | WO2004002424A8 Mammalian epo mimetic ch1 deleted mimetibodies, compositions, methods and uses |
| 06/30/2005 | WO2004001381A3 Novel raag10 cell surface target and a family of antibodies recognizing that target |
| 06/30/2005 | WO2003064629A3 Therapeutic polypeptides, nucleic acids encoding same, and methods of use |
| 06/30/2005 | WO2002091999A3 Treatment for wounds |
| 06/30/2005 | US20050144680 hybrid plants and seeds having herbicide, insect and disease resistance; genetic engineering |
| 06/30/2005 | US20050144675 Soybean cultivar S030156 |
| 06/30/2005 | US20050144674 Soybean cultivar s030159 |
| 06/30/2005 | US20050144667 Plant polypeptides and polynucleotides encoding same |
| 06/30/2005 | US20050144660 Mouse models for studying and treating hepatocellular and gastrointestinal tumors |
| 06/30/2005 | US20050144657 Transfecting rhesus papillomavirus (RhPV) genome into raft culture of rhesus cervical cells or foreskin keratinocytes with DNA molecule; inducing heat shock protein 40 and 70 expression enhancing viron growth |
| 06/30/2005 | US20050144655 Methods of modifying eukaryotic cells |
| 06/30/2005 | US20050144109 Electronic trading data integration and protection system |
| 06/30/2005 | US20050143802 Implantable system with drug-eluting cells for on-demand local drug delivery |
| 06/30/2005 | US20050143564 transformed plant cell is obtained by introducing to a plant cell a gene encoding a glycosyltransferase enzyme and a gene encoding an exogenous glycoprotein, cultivating the obtained transformed plant cell |
| 06/30/2005 | US20050143559 Tryparedoxin, expression plasmid, process of preparation, method of use, test kit and pharmaceutical composition |
| 06/30/2005 | US20050143388 Nitric oxide donors for treatment of disease and injury |
| 06/30/2005 | US20050143308 Survivin, a protein that inhibits cellular apoptosis, and its modulation |
| 06/30/2005 | US20050143293 Peptides for enhancing resistance to microbial infections |
| 06/30/2005 | US20050142660 culturing cells in cultures and harvesting the conditioned medium from the cultures, wherein the cells used to condition the medium are differentiated cells; conditioned medium that enhances the viability and/or cell proliferation |
| 06/30/2005 | US20050142659 Purified populations of stem cells |
| 06/30/2005 | US20050142658 Chromosomal saturation mutagenesis |
| 06/30/2005 | US20050142640 MUC-1 derived peptides |
| 06/30/2005 | US20050142639 Nucleotide sequence with vectors and administering apolipoproteins with data documents for binding lipids and cubulin for treatment of cardiovascular disorders |
| 06/30/2005 | US20050142635 chimeric antibodies comprising variable domain peptides, DNA codes for the antibodies, expression vectors, host cells and a process of culturing the host cells to produce the monoclonal antibodies, used for immunotherapy; nonimmunogenic |
| 06/30/2005 | US20050142634 Novel modulator of non-genomic activity of nuclear receptors (mnar) and uses thereof |
| 06/30/2005 | US20050142632 mixture of components from collagenases and components from proteases from clostridium, used for improving the isolation results with respect to yield, viability and integrity of the cells |
| 06/30/2005 | US20050142628 Use |
| 06/30/2005 | US20050142625 monoclonal antibodies or antigen-binding fragments having specific binding affinity to an epitope of protein kinases polypeptides, used for the diagnosis and treatment of various kinase-related diseases in humans |
| 06/30/2005 | US20050142617 gene related to bone density; possible use in the drug screening, treatment, and diagnosis of bone disorders such as osteoporosis |
| 06/30/2005 | US20050142609 Native immunoglobulin binding reagents and methods for making and using same |
| 06/30/2005 | US20050142566 Sperm-specific cation channel, catSper2, and uses therefor |
| 06/30/2005 | US20050142553 Serine hydroxymethyltransferase as a target for herbicides |
| 06/30/2005 | US20050142550 Increased copy number of a nucleic acid linked to a reporter nucleic acid; screen cells for increased expression of a polypeptide derived from the nucleic acid, and related cell |
| 06/30/2005 | US20050142548 Allelic variants of grp50 |
| 06/30/2005 | US20050142546 Assays for identifying modulators of rhomboid polypeptides |
| 06/30/2005 | US20050142149 Virulence genes and proteins, and their use |
| 06/30/2005 | US20050142146 Vaccine; against Chlamydia pneumonia; therapy, prevention of infections, |
| 06/30/2005 | US20050142144 Epitope sequences |
| 06/30/2005 | US20050142142 recombinant T cell receptor ligand (RTL) for use treating autoimmune diseases |
| 06/30/2005 | US20050142139 and a histidine buffer; anti-HIV; higher concentrations, are storage stable, compatible with lyophilization, and safe to administer by intravenous injection |
| 06/30/2005 | US20050142138 Endothelial cell expression patterns |
| 06/30/2005 | US20050142131 use treating diseases associated with amyloid beta (A beta), such as Alzheimer's disease, Down's syndrome, and cerebral amyloid angiopathy; host cells |
| 06/30/2005 | US20050142121 Preparing cells for engraftment by differentiating human embryonic stem cells into a particular tissue type, and adapting the cell population to decrease the amount of uric acid produced by the cells upon transplantation into a subject; regenerative medicine |
| 06/30/2005 | US20050142120 Cells expressing anti-Fc receptor binding components |
| 06/30/2005 | US20050142119 Pluri-differentiated mesenchymal progenitor cell for use as tissue propagation tool in regenerative medicine; tissue engineering and repair |
| 06/30/2005 | US20050142118 Human cord blood derived unrestricted somatic stem cells (USSC) |
| 06/30/2005 | US20050142107 Use of IL-6-type cytokines for maturation of oocytes |
| 06/30/2005 | US20050142103 Mobilizing hematopoietic progenitor cells from bone marrow into peripheral blood by administration of an inhibitor of GTPases such as Rac1 and Rac2 alone or in combination; specifically, methods are disclosed for mobilizing hematopoietic stem cells into subject's peripheral blood; treating cancer, anemia |
| 06/30/2005 | US20050142102 Administering a hematopoietic growth factor such as granulocyte-colony stimulating factor and granulocyte-macrophage colony stimulating factor to a mammal; providing neuroprotection to the neural cells involved or to induce neurogenesis to recover from neuronal loss |
| 06/30/2005 | US20050142064 Administering test drug infected with adenovirus used as a vector and engineered by incorporating a detectable reporter gene and having human PXR binding regions falling within an untranslated region of a human CY3A gene; genetic engineering and expression; gene therapy; drug screening |
| 06/30/2005 | CA2588965A1 Novel chimeric plasminogen activators and their pharmaceutical use |
| 06/30/2005 | CA2550084A1 Stem cell targeting using magnetic particles |
| 06/30/2005 | CA2550028A1 Transgenic plants with reduced level of saturated fatty acid and methods for making them |
| 06/30/2005 | CA2549936A1 Dominant gene suppression transgenes and methods of using same |
| 06/30/2005 | CA2549930A1 Cd34+ stem cells |